EGFR and neoplasm: In addition, the expression of EGFR in tumours has been correlated with disease progression, poor survival, poor response to therapy (Brabender et al, 2000) and the development of resistance to cytotoxic agents (Wosikowski et al, 1997; Meyers et al, 1998).